Methafly 250 Tablet contains Metronidazole 250mg, a potent antibacterial and antiprotozoal agent indicated for the treatment of infections caused by anaerobic bacteria and protozoa, including gastrointestinal, gynecological, and parasitic infections. It helps in controlling microbial proliferation and alleviating infection-related symptoms.
Metronidazole works by inhibiting nucleic acid synthesis in susceptible microorganisms, causing cell death and effective eradication of the infection. Its broad-spectrum action ensures reliable management of bacterial and protozoal infections.
For distributors and healthcare suppliers, Metofoli 250 Tablet is a high-demand anti-infective product, widely prescribed in hospitals, clinics, and community healthcare setups. Its regular use for gastrointestinal and gynecological infections guarantees stable market turnover.
Adding Methafly 250 Tablet to your antibacterial and antiprotozoal therapy segment creates strong opportunities in pharmacies, hospitals, specialty clinics, export markets, and third-party manufacturing. Its proven clinical efficacy, broad applicability, and strong prescriber trust make it a valuable addition to pharmaceutical distribution portfolios.